Stay updated on Hepatic Impairment Impact on Risdiplam: Clinical Trial
Sign up to get notified when there's something new on the Hepatic Impairment Impact on Risdiplam: Clinical Trial page.

Latest updates to the Hepatic Impairment Impact on Risdiplam: Clinical Trial page
- Check5 days agoChange DetectedAdded Revision: v3.3.2, replacing Revision: v3.3.1, indicating a system/UI update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page now lists Revision: v3.3.1 and no longer shows Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding notice banner at the top of the study record was removed. The page still shows the study details, eligibility criteria, and locations.SummaryDifference0.4%

- Check34 days agoChange DetectedNo substantive changes are visible between the two screenshots; the study details and page sections remain unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedCore updates include a status/operational notice about funding and a new resource entry (Spinal muscular atrophy), plus a version bump to v3.2.0. The funding notice is the most impactful change for users.SummaryDifference3%

- Check70 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, indicating a newer release. Overall meaning remains the same with an explicit version bump.SummaryDifference0.1%

Stay in the know with updates to Hepatic Impairment Impact on Risdiplam: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Hepatic Impairment Impact on Risdiplam: Clinical Trial page.